Concourse Financial Group Securities, Inc. Heart Test Laboratories, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024
BUY
$0.11 - $0.18 $0 - $0
0 New
0 $0
Q4 2023

Feb 07, 2024
BUY
$0.15 - $0.43 $0 - $0
0 New
0 $0
Q3 2023

Oct 30, 2023
BUY
$0.38 - $0.98 $0 - $0
0 New
0 $0
Q3 2023

Oct 25, 2023
BUY
$0.38 - $0.98 $0 - $0
0 New
0 $0
Q2 2023

Aug 10, 2023
BUY
$0.83 - $1.26 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$0.78 - $3.4 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$0.8 - $267.0 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$1.15 - $126.0 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$1.78 - $170.0 $0 - $0
0 New
0 $0

About Heart Test Laboratories, Inc.

HSCS Quotes by TradingView
  • Ticker HSCS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,202,550
  • Market Cap $23.8M
  • Description
  • Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urg...
More about HSCS
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email